Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Study the Clinical Treatment Plan of Lung Injury Caused by Major Infectious Diseases Treated With Stem Cells

NCT06416709 is registered in ClinicalTrials.gov with Cell Energy Life Sciences Group Co. LTD as lead sponsor.

NCT NCT06416709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06416709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Study the Clinical Treatment Plan of Lung Injury Caused by Major Infectious Diseases Treated With Stem Cells
Lead sponsor
Cell Energy Life Sciences Group Co. LTD
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 10, 2023
Completion date
May 10, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung injury